Literature DB >> 29062323

The burden, pattern and factors that contribute to periportal fibrosis in HIV-infected patients in an S. mansoni endemic rural Uganda.

Ponsiano Ocama1, Kenneth Christopher Opio1, Emmanuel Seremba1, Paul Ajal2, Betty Stephanie Apica1, Emmanuel Odongo Aginya3.   

Abstract

INTRODUCTION: Both Human Immunodeficiency Virus (HIV) and S.mansoni infections are common in Uganda and can cause liver disease. No study has determined co-infection significance in Uganda. We carried out a study on the burden, pattern and factors that contribute to peri-portal fibrosis (PPF) in HIV infected patients attending a Primary healthcare setting at Pakwach.
METHODOLOGY: We conducted a cross-sectional study in the HIV clinic at Pakwach health centre IV. Data on demographics, contact with the Nile, CD4+ cell count, ART and alcohol use were collected. Urinary Circulating Cathodic Antigen (CCA), was done for S. Mansoni detection. Liver scan was done for presence and pattern of PPF. HBsAg testing was performed on all participants. Data was analyzed using Stata Version 10.
RESULTS: We enrolled 299 patients, median age 39 years (IQR 16), most were female, 210 (73%). Overall, 206 (68.9%) had PPF, majority 191 (92.7%) had pattern c, either alone (63 participants) or in combination with pattern d (128 participants). Age of 30-50 years was significantly associated with PPF (OR 2.28 p-value-0.003).
CONCLUSION: We found high prevalence of S. mansoni and PPF in the HIV infected population and age was a significant factor for PPF. We recommend all HIV infected patients be examined routinely for S. mansoni infection for early anti-schistosomal treatment.

Entities:  

Keywords:  HIV; S.Mansoni; peri-portal fibrosis

Mesh:

Year:  2017        PMID: 29062323      PMCID: PMC5637013          DOI: 10.4314/ahs.v17i2.2

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  14 in total

1.  Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya.

Authors:  W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-10-13       Impact factor: 2.743

2.  Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia.

Authors:  Nega Berhe; Jonn T Geitung; Girmay Medhin; Svein G Gundersen
Journal:  Trop Med Int Health       Date:  2006-08       Impact factor: 2.622

Review 3.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

4.  Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis.

Authors:  J Russell Stothard; Narcis B Kabatereine; Edridah M Tukahebwa; Francis Kazibwe; David Rollinson; William Mathieson; Joanne P Webster; Alan Fenwick
Journal:  Acta Trop       Date:  2005-12-28       Impact factor: 3.112

5.  Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda.

Authors:  N B Kabatereine; J Kemijumbi; J H Ouma; H C Kariuki; J Richter; H Kadzo; H Madsen; A E Butterworth; N Ørnbjerg; B J Vennervald
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-12       Impact factor: 2.184

Review 6.  The changing epidemiology of liver disease in HIV patients.

Authors:  Vincent Soriano; Pablo Barreiro; Kenneth E Sherman
Journal:  AIDS Rev       Date:  2013 Jan-Mar       Impact factor: 2.500

7.  Schistosoma mansoni in Pachwach, Nebbi District, Uganda, 40 years after Nelson.

Authors:  N B Kabatereine; C Ariho; N O Christensen
Journal:  Trop Med Parasitol       Date:  1992-09

8.  Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya.

Authors:  Hillary L Shane; Jennifer R Verani; Bernard Abudho; Susan P Montgomery; Anna J Blackstock; Pauline N M Mwinzi; Sara E Butler; Diana M S Karanja; W Evan Secor
Journal:  PLoS Negl Trop Dis       Date:  2011-01-25

9.  High incidence of HIV-1 infection in a general population of fishing communities around Lake Victoria, Uganda.

Authors:  Noah Kiwanuka; Ali Ssetaala; Annet Nalutaaya; Juliet Mpendo; Matthias Wambuzi; Annet Nanvubya; Simon Sigirenda; Paul Kato Kitandwe; Leslie Elizabeth Nielsen; Apolo Balyegisawa; Pontiano Kaleebu; Josephine Nalusiba; Nelson Kaulukusi Sewankambo
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

10.  Periportal fibrosis, liver and spleen sizes among S. mansoni mono or co-infected individuals with human immunodeficiency virus-1 in fishing villages along Lake Victoria shores, North-Western, Tanzania.

Authors:  Humphrey D Mazigo; David W Dunne; Domenica Morona; Therese E Lutufyo; Safari M Kinung'hi; Geofrey Kaatano; Fred Nuwaha
Journal:  Parasit Vectors       Date:  2015-05-07       Impact factor: 4.047

View more
  3 in total

1.  Interactions of Schistosoma and HIV in Sub-Saharan Africa: A Systematic Review.

Authors:  Briana D Furch; John R Koethe; Violet Kayamba; Douglas C Heimburger; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

2.  Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, Uganda.

Authors:  Alison M Elliott; Meta Roestenberg; Anne Wajja; Christopher Opio; Francis Angumya; Moses Adriko; Moses Egesa; Serah Gitome; Joseph Mfutso-Bengo; Philip Bejon; Melissa Kapulu; Zoe Seager; Tom Lutalo; Winfred Badanga Nazziwa; Asuman Muwumuza; Maria Yazdanbakhsh; Pontiano Kaleebu; Narcis Kabatereine; Edridah Tukahebwa
Journal:  AAS Open Res       Date:  2018-08-06

3.  Contribution of Schistosoma mansoni to systemic inflammation and microbial translocation among people with HIV in Zambia.

Authors:  Briana D Furch; Simutanyi Mwakamui; Sandie Sianongo; Kanekwa Zyambo; Douglas C Heimburger; John R Koethe; Paul Kelly
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-02-01       Impact factor: 2.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.